ProFunds Biotechnology UltraSector Fund Investor Class BIPIX:NASDAQ

Net Asset Value$67.01Closing Price - 8/14/2018
1-Day Change+0.29(0.43%)
YTD Change+4.54(7.27%)

Growth of $10,000 Since Fund Inception

View portfolioPortfolio as of 04/30/2018

Top 5 SectorsTop 5 Holdings
Health Technology72.97%
AbbVie Inc ORD14.53%
Health Services1.52%
Amgen Inc ORD11.01%
Commercial Services0.86%
Gilead Sciences Inc ORD8.94%
  
Celgene Corp ORD6.19%
  
Biogen Inc ORD5.47%
Concentration of Top 575.35% Concentration of Top 546.14% 

Fund Profile

Fund Strategy

The Fund seeks daily investment results, before fees and expenses, that correspond to 150% of the performance of the Dow Jones U.S. Biotechnology Index.

Fund Category Sector Equity
Inception Date 06/19/2000
Manager Neches/Lowery
Fund Classification Equity Leverage Funds
Managed Since 2013
Other Managed Funds   INPIX  SMPIX  CYPIX  TEPIX  ENPIX

Lipper Leader Scorecard as of 07/31/2018

RatingTotal
Return
Consistent
Return
PreservationTax
Efficiency
Expense*
Overall Rating(# of funds in category)
179

175

12,054

179

41
3 Year Rating(# of funds in category)
179

177

12,054

179

41
5 Year Rating(# of funds in category)
154

153

10,220

154

40
10 Year Rating(# of funds in category)
107

107

6,833

107

39

Fund Highlights

Total Expense Ratio1.45%
Average Market Capitallization$75.0 B
Net Asset ValueN/A
Total Net Assets$245.5 M
Sales ExpensesNo Load Fund
Minimum Initial Investment$15000
Minimum IRA Investment$15000
AvailabilityOpen to New Investors
Current Yield0.00%
Dividend Ex-DateN/A

Risk Analysis

Beta vs. S&P 5002.47
R-Squared vs. S&P 5000.58
Standard Deviation31.73%
Sharpe Ratio-0.02
Portfolio TurnoverN/A